Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/08/2007US20070054915 e.g. [6-(2,4-Difluoro-phenoxy)-1H- pyrazolo[3,4-d]pyrimidin-3-yl]- isopropyl-amine; preferential enzyme inhibitors; antiinflammatory agent; arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease
03/08/2007US20070054914 Eszopiclone process
03/08/2007US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
03/08/2007US20070054912 Modulators of acetylcholine receptors
03/08/2007US20070054911 Muscarinic modulators
03/08/2007US20070054910 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
03/08/2007US20070054909 VLA-4 inhibitor compounds
03/08/2007US20070054908 Novel pharmaceutical compositions and methods for treating tumors, including drug-resistant tumors
03/08/2007US20070054907 Peroxisome Proliferator-Activated Receptor (PPAR) receptor modulators such as Ethyl(4-{4-[5-(4-tert-butylphenyl)-4-methyl-4H-[1,2,4]-triazol-3-ylsulfanyl]-2-heptyloxybenzylamino}phenyl)acetate, used in dermatology, cardiovascular diseases, immunology and/or diseases linked to lipid metabolism
03/08/2007US20070054906 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/08/2007US20070054905 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
03/08/2007US20070054904 Phenol derivatives and their use as rotamase inhibitors
03/08/2007US20070054903 Bis-aryl kinase inhibitors and method
03/08/2007US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists
03/08/2007US20070054901 Dihydrothiazine prodrugs of thiazolium agents
03/08/2007US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
03/08/2007US20070054899 Aromatase inhibitor compounds and uses thereof
03/08/2007US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes
03/08/2007US20070054896 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
03/08/2007US20070054895 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer
03/08/2007US20070054894 Quinazoline potassium channel inhibitors
03/08/2007US20070054893 Prostaglandin analogs
03/08/2007US20070054892 Isoquinoline potassium channel inhibitors
03/08/2007US20070054891 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent, antidepressant; eating disorders, obesity, nicotine addiction
03/08/2007US20070054890 Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
03/08/2007US20070054889 Injectable sterile pharmaceutical formulation containing at least two active principles
03/08/2007US20070054888 Novel substituted diamine derivatives useful as motilin agonists
03/08/2007US20070054887 Benign prostatic hyperplasia, hyptertrophy, overactivity; giving vitamin D receptor agonists: calcitrol, 1-a-fluoro-25-hydroxy-16,23-diene-26,27-bishomo-20-epi-cholecalciferol, 1,25-dihydroxy-16-ene-23-yne cholecalciferol, 1,3-di-O-acetyl-1,25-dihydroxy-16,23-diene-26,27-hexafluoro-19-nor-cholecalciferol
03/08/2007US20070054886 Ras antagonists for treating neurodegenerative disorders
03/08/2007US20070054885 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
03/08/2007US20070054884 4-substituted 2-aryloxyphenol derivatives as antibacterial agents
03/08/2007US20070054883 Use controlling growth of quorum-sensing bacteria, controlling biofilm formation, including biofilm growth; cyclic borate, phosphate or sulfate compounds
03/08/2007US20070054882 Male anti-fertility agents
03/08/2007US20070054881 Anxiolytic agents with reduced sedative and ataxic effects
03/08/2007US20070054880 Cellulose oxidation by nitrogen dioxide in a perfluorinated tertiary amine solvent
03/08/2007US20070054879 Beta-chitin complex and method for producing the same
03/08/2007US20070054878 Use of hyaluronic acid derivatives for inhibiting inflammatory arthritis
03/08/2007US20070054877 Antiadhesive carbohydrates
03/08/2007US20070054876 Pharmaceutical composition promoting defecation
03/08/2007US20070054875 For therapy of cardiovascular disease, ischemia related injuries; and neurodegenerative diseases, Alzheimer's disease, Parkinson's disease
03/08/2007US20070054874 Methods for the selective treatment of tumors by calcium-mediated induction of apoptosis
03/08/2007US20070054873 Glucocorticoid modulation of nucleic acid-mediated immune stimulation
03/08/2007US20070054870 glycomimetics; selectin binding modulators for use in treatment ofinflammatory, autoimmune, infection, cancer, shock, thrombosis, wounds, burns, reperfusion injury, blood, leukocyte-mediated lung injury, spinal cord damage, digestive tract mucous membrane disorders, osteoporosis, arthritis and asthma
03/08/2007US20070054868 Synergistic polyphenol compounds, compositions thereof, and uses thereof
03/08/2007US20070054867 Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments
03/08/2007US20070054862 Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing an Adenosine Kinase
03/08/2007US20070054859 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
03/08/2007US20070054844 topically administering to a otitis externa patient an antifungal agent such as fluconazole, voriconazole, itraconazole, clotrimazole and amphotericin B, and an antibacterial agent such as neomycin sulfate, polymyxin B sulfate with an excipient
03/08/2007US20070054839 Method of inhibiting remnant lipoprotein production
03/08/2007US20070054838 Method for improving diagnostic quality in echocardiography
03/08/2007US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders
03/08/2007US20070054355 Cbl-b polypeptides, complexes and related methods
03/08/2007US20070054330 determining whether a biological sample comprising human lung cancer cells is sensitive to a combination of an epidermal growth factor receptor inhibitor and a chemotherapeutic agent by determining the overexpression of a phosphorylated AKT protein
03/08/2007US20070054284 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
03/08/2007US20070053999 5.0%-70.0% by weight Radix Salviae Miltiorrhizae extract;10.0%-85.0% by weight Radix Notoginseng extract;5.0%-70.0% by weight Radix Astragali extract; and1.0%-15.0% by weight Borneol or oil of Lignum Dalbergiae Odoriferae; combined therapy with reduced side effects
03/08/2007US20070053996 Light-activated cation channel and uses thereof
03/08/2007US20070053995 comprising tolterodine and pilocarpine; drug releasing pilocarpine between about 15 minutes to about 30 minutes after tolterodine is released; depending on the peak of saliva flow time; urogenital disorders
03/08/2007US20070053994 Anti-inflammatory treatment
03/08/2007US20070053993 Method to predict and prevent oxygen-induced inflammatory tissue injury
03/08/2007US20070053985 Coenzyme Q10-containing fine particle with excellent dispersibility
03/08/2007US20070053984 Topical gels compositions
03/08/2007US20070053983 Extended release compositions of metoprolol succinate
03/08/2007US20070053982 Sustained release oral formulations
03/08/2007US20070053980 Extended release tiagabine formulations with reduced side-effects
03/08/2007US20070053979 Controlled release formulation of erythromycin derivatives
03/08/2007US20070053976 Synergistic donepezil hydrochloride and a selective serotonin reuptake inhibitor, milnacipran, or duloxetine administered seperately or concurrently
03/08/2007US20070053975 Ramipril formulation
03/08/2007US20070053974 Stable oral composition
03/08/2007US20070053973 Amorphous antibiotic composition comprising cefditoren pivoxil
03/08/2007US20070053971 Antimicrobial and Antiviral Compounds and Methods for their Use
03/08/2007US20070053970 Liposomal formulation for oral administration of glutathione (reduced) and/or methylcobalamine for diseases related to glutathione deficiency and deficiency of the methionine remethylation pathway
03/08/2007US20070053968 Transdermal drug delivery devices containing O-Desmethyl Venlafaxine (ODV) or its salts
03/08/2007US20070053966 Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
03/08/2007US20070053964 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist
03/08/2007US20070053960 Multiribbon nanocellulose as a matrix for wound healing
03/08/2007US20070053958 Elastomeric gloves and methods of making
03/08/2007US20070053957 Agents for controlling biological fluids and methods of use thereof
03/08/2007US20070053955 Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
03/08/2007US20070053952 Nitric oxide-releasing polymers derived from modified polymers
03/08/2007US20070053943 Dimethicone-containing sustained release injection formulation
03/08/2007US20070053942 Disinfectant and/or bactericidal aqueous compositions
03/08/2007US20070053939 Biguanide drug-containing jelly preparation
03/08/2007US20070053934 Polyvalent multimeric composition containing active polypeptides, pharmaceutical compositions and methods of using the same
03/08/2007US20070053930 Combination therapy for treatment of high cholesterol
03/08/2007US20070053918 Injectable depots consisting of liposomal aggregates for the delivery of active substances
03/08/2007US20070053917 Composition and method for the treatment and prevention of enteric bacterial infections
03/08/2007US20070053916 Plasmodium falciparum peptide for use in stimulating immune response to treat and prevent malaria
03/08/2007US20070053893 Method of reducing immunological tolerance to malignancy
03/08/2007US20070053892 Methods and kits for co-administration of nutritional supplements
03/08/2007US20070053883 Neuronal cell lineages and methods of production thereof
03/08/2007US20070053870 Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release comprising the same and preparation method thereof
03/08/2007US20070053869 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents
03/08/2007US20070053868 Solvent system for enhancing the solubility of pharmaceutical agents
03/08/2007US20070053865 Poly(potassium and sodium styrene sulfonate) its manufacture and its uses
03/08/2007US20070053864 Poly(potassium and sodiumstyrene sulfonate) its manufacture and its uses
03/08/2007US20070053861 Ophthalmic composition for contact lens
03/08/2007US20070053858 Personal care composition
03/08/2007US20070053849 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
03/08/2007US20070053845 Nanocell drug delivery system
1 ... 3847 3848 3849 3850 3851 3852 3853 3854 3855 3856 3857 3858 3859 3860 3861 3862 3863 3864 3865 3866 3867 ... 7860